DOCK8 DEFICIENCY

Clinical trials for DOCK8 DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new DOCK8 DEFICIENCY trials appear

Sign up with your email to follow new studies for DOCK8 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Stem cell transplant offers hope for rare immune disorder

Disease control Ongoing

This study tests whether a stem cell transplant from a matched sibling, unrelated donor, or half-matched parent can fix the immune system in people with DOCK8 deficiency, a genetic condition that causes severe infections and cancer. Participants aged 4 to 35 receive chemotherapy …

Matched conditions: DOCK8 DEFICIENCY

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

DOCK8 DEFICIENCY

Get alerted when new DOCK8 DEFICIENCY trials appear

Stem cell transplant offers hope for rare immune disorder